RH
Robert Arthur Harrington (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Cytokinetics, Incorporated (CYTK). The largest single filing was $144K of CYTK (2,150 sh × $66.80, as filed), executed Dec 1 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$144K
shares × price, as filed
Last traded
Dec 1 2025
Filed Dec 2 2025
Median ADV $207.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $248K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
CYTKRecent filings
CYTKSALE
Cytokinetics, Incorporated
View filing →
$144K2,150 sh × $66.80
Exec Dec 1 2025
Filed Dec 2 2025 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $105K
2,150 sh × $48.67
Exec Sep 2 2025
Filed Sep 2 2025 · 5:30 PM ET